Progenitor Cell Therapy LLC is categorized under Research and Development Laboratories in Mountain View, CA and active since 2004.
Progenitor Cell Therapy LLC was established in 2004, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 5417110 by the NAICS.
If you are seeking more information, feel free to contact Russell Hays at the company’s branch by writing to 291 Bernardo Avenue, Mountain View, California CA 94043 or by phoning (650) 964-6744. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Progenitor Cell Therapy LLC |
| Contact Person: | Russell Hays |
| Address: | 291 Bernardo Avenue, Mountain View, California 94043 |
| Phone Number: | (650) 964-6744 |
| Website Address: | neostem.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2004 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 5417110 |
| Share This Business: |
Progenitor Cell Therapy LLC was started in 2004 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Russell Hays for inquiries that concern Progenitor Cell Therapy LLC by calling the company number (650) 964-6744, as your correspondence is most welcome. Additionally, the physical location of the branch of Progenitor Cell Therapy LLC can be found at the coordinates 37.38785,-122.05159 as well as the street address 291 Bernardo Avenue in Mountain View, California 94043.
For its online presence, you may visit Progenitor Cell Therapy LLC’s website at neostem.com and engage with its social media outlets through on Twitter and on Facebook.